VEA-31703-35352
4 vaccinations
1 coded response
47 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 630 / MO
- Registered
- 2021-01-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Registered in v-safe
-
2021-01-25
Dose 1 — Pfizer-BioNTech
-
2021-01-25
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-01
- 2021-02-08
-
2021-02-15
Dose 2 — Pfizer-BioNTech
-
2021-02-15
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Nausea · Be unable to workAdult check-in
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-05-17
- 2021-08-16
-
2021-12-07
Dose 3 — Pfizer-BioNTech
-
2021-12-13
Survey response — days 1–6 daily, dose 3MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: FairFree text: Sore throat, nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-03-08
- 2022-06-07
-
2022-10-12
Dose 4 — Pfizer-BioNTech
-
2022-10-12
Health check-in — day 0, dose 4Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2022-10-13
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2023-01-11
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-15 | Pfizer-BioNTech | |
| 3 | 2021-12-07 | Pfizer-BioNTech | No |
| 4 | 2022-10-12 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat, nasal congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release